Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company manufactures and sells pharmaceutical products.
Cipla Limited, also popularly known as Cipla, is a listed public company incorporated on 17 August, 1935. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 175.00 cr and the total paid-up capital is INR 161.55 cr.
Read more
** All rupee values in INR crores. Based on March 2025 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Prathivadibhayankara Rajagopalan Ramesh | 01915274 | 4 years |
Director | Mandar Purushottam Vaidya | 09690327 | 3 years |
Director | Yusuf Khwaja Hamied
Shareholder
|
00029049 | 53 years |
Director | Adil Zainulbhai | 06646490 | 11 years |
Managing Director | Umang Vohra
Shareholder
|
02296740 | 9 years |
Director | Robert Stewart | 03515778 | 4 years |
Director | Kamil Hamied | 00024292 | 1 years |
Director | Maya Hari | 01123969 | 1 years |
Director | Abhijit Jagdish Joshi | 07115673 | 1 years |
Director | Sharmila Nitin Paranjpe | 02328770 | 1 years |
Director | Balram Bhargava | 10479707 | 2 years |
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
ALPS REMEDIES PRIVATE LIMITED |
Active
|
20.2 L | 1 | Maharashtra |
HAMSONS LABORATORIES PRIVATE LIMITED |
Converted to LLP and Dissolved
|
40.0 L | 1 | Maharashtra |
FLORAL FANTASY PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 1 | Maharashtra |
FKH INVESTMENTS PRIVATE LIMITED |
Active
|
2.0 Cr | 1 | Maharashtra |
STYLKIST LIFESTYLE PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
FORUM FOR INDIAN ACCOUNTING RESEARCH |
Active
|
0.0 | 1 | Telangana |
ITC HOTELS LIMITED |
Active
|
83.0 Cr | 1 | West Bengal |
NSE INVESTMENTS LIMITED |
Active
|
826.0 Cr | 1 | |
TEJAS NETWORKS LIMITED |
Active
|
176.7 Cr | 1 | Karnataka |
AIX CONNECT PRIVATE LIMITED |
Amalgamated
|
4,195.0 Cr | 1 | Haryana |
HOUSING DEVELOPMENT FINANCE CORPORATION LIMITED |
Amalgamated
|
370.3 Cr | 1 | Maharashtra |
ITC HOTELS LIMITED |
Active
|
208.3 Cr | 1 | West Bengal |
AIR INDIA EXPRESS LIMITED |
Active
|
3,017.1 Cr | 1 | Haryana |
LARSEN AND TOUBRO LIMITED |
Active
|
275.1 Cr | 1 | Maharashtra |
CROMPTON GREAVES CONSUMER ELECTRICALS LIMITED |
Active
|
128.8 Cr | 1 | Maharashtra |
AIR INDIA LIMITED |
Active
|
36,351.9 Cr | 1 | Haryana |
CYIENT LIMITED |
Active
|
55.5 Cr | 1 | Telangana |
NESTLE INDIA LIMITED |
Active
|
192.8 Cr | 1 | Delhi |
I-VEN PHARMA CAPITAL LIMITED |
Under Liquidation
|
8.9 L | 1 | Karnataka |
STEMPEUTICS RESEARCH PRIVATE LIMITED |
Active
|
63.6 Cr | 1 | Karnataka |
CIPLA HEALTH LIMITED |
Active
|
2.3 Cr | 1 | Maharashtra |
DOOR STEP SCHOOL FOUNDATION |
Active
|
0.0 | 1 | Maharashtra |
C3 MEDICARE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
SAMSHIKSHA FOUNDATION |
Active
|
0.0 | 1 | Delhi |
UNNATI EMPLOYMENT NETWORK |
Active
|
2.5 Cr | 1 | Delhi |
PIRAMAL FOUNDATION |
Active
|
0.0 | 1 | Maharashtra |
OPEN NETWORK FOR DIGITAL COMMERCE |
Active
|
864.0 Cr | 1 | |
TV18 BROADCAST LIMITED |
Amalgamated
|
342.9 Cr | 1 | Maharashtra |
NETWORK18 MEDIA & INVESTMENTS LIMITED |
Active
|
771.0 Cr | 1 | Maharashtra |
RELIANCE RETAIL LIMITED |
Active
|
8,987.0 Cr | 1 | Maharashtra |
STEP UP CHARITABLE FOUNDATION |
Active
|
80,000.0 | 1 | Maharashtra |
NAVIN FLUORINE INTERNATIONAL LIMITED |
Active
|
10.2 Cr | 1 | Maharashtra |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
JAY PRECISION PHARMACEUTICALS PRIVATE LIMITED | 2012 | ₹ 4.0 Cr | |
MEDITAB SPECIALITIES LIMITED | Maharashtra | 1996 | ₹ 71.2 L |
MEDISPRAY LABORATORIES PRIVATE LIMITED | Goa | 1992 | ₹ 5.1 L |
GOLDENCROSS PHARMA LIMITED | Maharashtra | 2000 | ₹ 4.6 L |
SITEC LABS LIMITED | Maharashtra | 2000 | ₹ 1.6 L |
CIPLA HEALTH LIMITED | Maharashtra | 2015 | ₹ 2.3 Cr |
CIPLA PHARMA AND LIFE SCIENCES LIMITED | Maharashtra | 2008 | ₹ 258.7 Cr |
CIPLA PHARMACEUTICALS LIMITED | Maharashtra | 2019 | ₹ 170.0 Cr |
CIPLA DIGITAL HEALTH LIMITED | Maharashtra | 2022 | ₹ 38.0 Cr |
Cipla Medpro South Africa (Pty) Limited | South Africa | - | - |
Meditab Holdings Limited | Mauritius | - | - |
Cipla Algerie | Algeria | - | - |
Cipla Europe NV | Belgium | - | - |
Cipla Holding B.V. | Netherlands | - | - |
Cipla Gulf FZ – LLC | United Arab Emirates | - | - |
Cipla Malaysia Sdn. Bhd. | Malaysia | - | - |
Breathe Free Lanka (Private) Limited | Sri Lanka | - | - |
Cipla Maroc SA | Morocco | - | - |
Cipla Australia Pty Limited | Australia | - | - |
Cipla Brasil Importadora E Distribuidora De Medicamentos Ltda. | Brazil | - | - |
Cipla EU Limited | United Kingdom | - | - |
Cipla Colombia SAS | Colombia | - | - |
Cipla (Jiangsu) Pharmaceutical Co., Limited | China | - | - |
Cipla (China) Pharmaceutical Co., Limited | China | - | - |
Cipla USA Inc. | United States | - | - |
InvaGen Pharmaceuticals Inc. | United States | - | - |
Exelan Pharmaceuticals Inc. | United States | - | - |
Cipla Kenya Limited | Kenya | - | - |
Cipla Therapeutics Inc | United States | - | - |
Cipla Medpro Manufacturing (Pty) Limited | South Africa | - | - |
Cipla-Medpro (Pty) Limited | South Africa | - | - |
Cipla-Medpro Distribution Centre (Pty) Limited | South Africa | - | - |
Cipla Medpro Botswana (Pty) Limited | Botswana | - | - |
Cipla Select (Pty) Limited (Formerly known as Cipla OLTP Proprietary Limited) | South Africa | - | - |
Medpro Pharmaceutica (Pty) Limited | South Africa | - | - |
Mirren (Pty) Limited | South Africa | - | - |
Actor Pharma (Pty) Limited | South Africa | - | - |
Aspergen Inc | United States | - | - |
Mexicip S.A. de C.V. | Mexico | - | - |
Cipla Health Employees Stock Option Trust | India | - | - |
The Cipla Empowerment Trust | South Africa | - | - |
Read more
The incorporation date of CIPLA LIMITED is 17 August, 1935
The authorized share capital of CIPLA LIMITED is INR ₹ 175.0 Cr.
The paid-up capital of CIPLA LIMITED is INR ₹ 161.6 Cr.
The registered address of CIPLA LIMITED is Cipla House, Peninsula Business Park Ganpatrao Kadam Marg, Lower Parel, Mumbai City, Mumbai, Maharashtra, India, 400013 - 400013
The CIN number of CIPLA LIMITED is L24239MH1935PLC002380.